SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C.  20549


                                    FORM 8-K


                                 CURRENT REPORT

                         PURSUANT TO SECTION 13 OR 15(D)
                     OF THE SECURITIES EXCHANGE ACT OF 1934


        DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED) JANUARY 10, 2003
                                                         ----------------



                                      AMPLIDYNE, INC.
              ----------------------------------------------------
              EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)


     DELAWARE                       0-21931                22-3440510
     ----------------------------------------------------------------------
    (STATE OR OTHER               (COMMISSION             (IRS EMPLOYER
     JURISDICTION OF               FILE NUMBER)          IDENTIFICATION NO.)
      INCORPORATION)



           59 LAGRANGE STREET,  RARITAN  NEW JERSEY              08869
       -------------------------------------------------------------------
       (ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)                (ZIP CODE)



        REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE (908) 253-6870
                                                           --------------


              ____________________________________________________
          (FORMER NAME OR FORMER ADDRESS, IF CHANGES SINCE LAST REPORT)



ITEM  5.        OTHER  EVENTS.
                --------------

     On  January  10,  2003, Amplidyne, Inc. (the "Company") was notified by The
Nasdaq  Stock  Market  that  its  request  to  continue  listing  the  Company's
securities on The Nasdaq SmallCap Market was denied.  Accordingly, the Company's
securities were delisted from The Nasdaq SmallCap Market effective with the open
of  business on January 14, 2003.  The Company's securities commenced trading on
the  OTC  Bulletin  Board  on  January  14,  2003  under  the  symbol  AMPD.OB.



                                        2


                                    SIGNATURE
                                    ---------


          Pursuant  to  the requirements of the Securities Exchange Act of 1934,
the  Registrant  has  duly  authorized  and  caused the undersigned to sign this
Report  on  the  Registrant's  behalf.


                                           AMPLIDYNE,  INC.



                                           By: /s/Devendar  S.  Bains
                                               --------------------------------
                                           Name:  Devendar  S.  Bains
                                           Title: Chief  Executive  Officer

Dated:  January  22,  2003
                                        3